Skip to content
  • Clinical Studies
  • Pharma Tips
  • Pharma GMP
  • Pharma SOP
  • Pharma Books
  • Schedule M
  • Pharma Validations
  • Pharma Regulatory
logo.png

StabilityStudies.in

Pharma Stability: Insights, Guidelines, and Expertise

  • Home
  • Stability Studies SOP
  • Stability Study Tips
  • Stability Studies Blog
  • Stability Studies FAQ
  • Toggle search form

Checklist for Requalification After Equipment Changes

Posted on By

In a GMP-regulated pharmaceutical facility, equipment validation is not a one-time task. Regulatory bodies expect requalification after certain changes to ensure ongoing fitness-for-purpose. This checklist-style guide provides global pharma professionals with a complete breakdown of what must be considered when requalifying equipment—especially in stability testing contexts—after planned or unplanned changes.

When Is Equipment Requalification Required?

According to global guidelines like EU GMP Annex 15 and USFDA guidance, requalification is mandated when:

  • ✅ The equipment has been moved to a new location
  • ✅ Core components are upgraded or replaced (e.g., sensors, controllers)
  • ✅ Software or firmware updates alter functionality
  • ✅ Extended downtime has occurred
  • ✅ Process parameters have changed significantly

Failing to conduct appropriate requalification after such changes can result in audit findings or worse—compromised product stability data.

Step-by-Step Requalification Checklist

1. Initiate Change Control

  • ✅ Raise a change control (CC) document with reference to equipment ID and affected systems
  • ✅ Assign a unique CC number and document the reason for change
  • ✅ Perform impact assessment with QA and Validation teams
  • ✅ Define requalification requirements in the CC approval

2. Perform Risk Assessment (ICH Q9 Aligned)

  • ✅ Use a risk-ranking matrix to assess potential impact on product quality
  • ✅ Determine the level of requalification: full, partial, or targeted
  • ✅ Document mitigation strategies if
any risk is detected

3. Update the Validation Master Plan (VMP)

  • ✅ Reflect the change and requalification activity in the VMP
  • ✅ Add reference to related PQ/OQ re-execution protocols
  • ✅ Ensure traceability to change control and risk assessment

Key Requalification Elements for Stability Equipment

For chambers, incubators, and photostability equipment used in stability studies, requalification typically includes:

  • ✅ Verification of temperature/RH probes (calibrated traceable to NIST standards)
  • ✅ Re-execution of mapping studies using calibrated data loggers
  • ✅ Door-open recovery checks and alarm challenge testing
  • ✅ Software/firmware re-validation for any system updates
  • ✅ OQ test cases for modified functions (e.g., new sensor range)

Documentation Package for Audit Readiness

Compile the following as part of your validation folder:

  • ✅ Signed change control record
  • ✅ Completed risk assessment
  • ✅ Revised qualification protocols (OQ/PQ)
  • ✅ Raw data printouts and electronic files
  • ✅ Calibration certificates and traceability sheets
  • ✅ QA approval and closure memo

Documentation must be controlled and retained per your local SOP management system.

Requalification Frequency vs. Event-Based Approach

Some regulatory authorities expect both event-based and time-based requalification. Here’s how you balance the two:

  • ✅ Conduct event-based requalification when predefined triggers occur (e.g., equipment move, major repair)
  • ✅ Set periodic requalification intervals (e.g., every 2–3 years) based on historical chamber performance
  • ✅ Use stability study data trends to justify extending requalification cycles

Always ensure your requalification policy is justified and documented in your Validation Master Plan and approved by QA.

Common Mistakes to Avoid

During requalification, avoid these typical pitfalls:

  • ❌ Reusing outdated or irrelevant qualification protocols
  • ❌ Missing calibration or verification of new components
  • ❌ Inadequate risk documentation and change control justification
  • ❌ Lack of training documentation for operators using modified equipment
  • ❌ Incomplete data integrity controls for new data loggers/software

Cross-Functional Review and Final QA Release

Once testing is complete, follow this closure workflow:

  • ✅ Technical review by validation engineer or equipment owner
  • ✅ QA review for completeness, compliance, and traceability
  • ✅ Formal sign-off from QA Manager for release into GMP use
  • ✅ Document archiving in your electronic Document Management System (eDMS)

Maintain readiness for audits from global authorities like ICH, CDSCO, or FDA.

Conclusion

Requalification of stability testing equipment after change is a critical GMP requirement. This checklist ensures you meet international expectations, protect product integrity, and prevent audit findings. Whether validating new installations or addressing equipment upgrades, a robust requalification process supported by change control, risk management, and qualification testing will keep your operations inspection-ready.

Related Topics:

  • ICH Stability Guidelines: A Comprehensive Guide for… ICH Stability Guidelines: A Comprehensive Guide for Pharmaceutical Product Testing ICH Stability Guidelines: Ensuring Pharmaceutical Product Stability and Compliance Introduction…
  • Stability Study Design: A Comprehensive Guide for… Stability Study Design: A Comprehensive Guide for Pharmaceutical Product Testing Stability Study Design: Ensuring Pharmaceutical Product Quality and Regulatory Compliance…
  • Reference Standards and Sensor Calibration in… Reference Standards and Sensor Calibration in Pharmaceutical Equipment Reference Standards and Sensor Calibration in Pharmaceutical GMP Environments Introduction In the…
  • Stability Testing Conditions: A Comprehensive Guide… Stability Testing Conditions: A Comprehensive Guide for Pharmaceutical Product Testing Stability Testing Conditions: Ensuring Reliable and Accurate Pharmaceutical Stability Studies…
  • Stability Monitoring in Regulatory Post-Approval Changes Stability Monitoring in Regulatory Post-Approval Changes Stability Monitoring in Regulatory Post-Approval Changes: Best Practices for Compliance and Product Integrity Pharmaceutical…
  • Understanding the Validation Lifecycle for Stability… Validation of stability testing equipment is a critical part of ensuring consistent drug quality and regulatory compliance. From temperature-controlled chambers…
Equipment and Calibration, Validation of Stability Testing Equipment Tags:calibration verification, Change Control, deviation management, equipment requalification checklist, FDA validation guidance, GMP equipment changes, HVAC requalification, ICH Q9, operational qualification, performance qualification, pharma validation protocols, pharmaceutical equipment compliance, PQ re-execution, qualification vs. requalification, requalification audit readiness, requalification triggers, revalidation documentation, risk-based requalification, stability chamber validation, stability equipment lifecycle, temperature RH mapping, validation lifecycle, validation SOPs, WHO TRS Annex 15

Post navigation

Previous Post: Test for Sedimentation and Redispersibility in Suspensions During Stability
Next Post: SOP for Conducting Stability Testing for Modified-Release Formulations in Compliance with Regulatory Guidelines

Quick Guide

  • Stability Testing Types (261)
    • Types of Stability Studies (75)
    • Real-Time and Accelerated Stability Studies (53)
    • Intermediate and Long-Term Stability Testing (52)
    • Freeze-Thaw and Thermal Cycling Studies (53)
    • Photostability and Oxidative Stability Studies (55)
    • Stability Testing for Biopharmaceuticals (49)
  • Regulatory Guidelines (169)
    • ICH Stability Guidelines (Q1A–Q1E, Q8, Q9, etc.) (23)
    • Regional Guidelines: FDA, EMA, ASEAN, TGA (21)
    • Significant Changes and Data Integrity Compliance (20)
    • Out-of-Specification (OOS) Stability Studies (21)
    • Global Harmonization of Stability Testing Regulations (22)
  • Equipment and Calibration (119)
    • Stability Chamber Calibration and SOPs (21)
    • Light, Humidity, and Temperature Monitoring in Stability (20)
    • Calibration of Lux Meters and Photostability Test Meters (1)
    • Validation of Stability Testing Equipment (21)
    • Impact of Equipment Deviations on Stability Data (21)
  • Protocols and Reports (108)
    • Stability Testing Report Generation and Documentation (21)
    • Stability Study Protocols for Different Drug Types (22)
    • ICH Q1E and Stability Data Evaluation (21)
    • Handling Deviations and CAPA in Stability Reports (22)
    • Outsourced Stability Storage and Testing Procedures (21)
    • Stability Documentation (74)
  • Pharmaceutical Quality and Practices (108)
    • Good Manufacturing Practices (GMP) for Stability Studies (22)
    • Quality by Design (QbD) in Stability Testing (21)
    • Risk-Based Approaches to Stability Testing (21)
    • Deviation and OOS Handling in Stability Testing (21)
    • Best Practices for Stability Testing Data Integrity (22)
  • Shelf Life and Expiry (99)
    • Shelf Life vs. Expiration Date: Key Differences (22)
    • Shelf Life Prediction Models and Statistical Approaches (20)
    • Factors Affecting Drug Shelf Life (Storage Conditions, Packaging, API Stability) (2)
    • Regulatory Submissions for Shelf Life Extensions (21)
    • Re-Test Period vs. Shelf Life in Pharmaceutical Stability (1)
  • Analytical Techniques in Stability Studies (6)
    • HPLC, GC, and Mass Spectrometry in Stability Testing (1)
    • Spectroscopic Methods for Stability Testing (FTIR, UV-Vis) (1)
    • Forced Degradation and Stress Testing Techniques (2)
    • Real-Time Monitoring of Degradation Pathways (1)
    • Regulatory Validation of Stability-Indicating Methods (1)
  • Stability Chambers and Environmental Monitoring (6)
    • ICH-Compliant Stability Chambers and Storage Conditions (1)
    • Environmental Monitoring in Stability Studies (1)
    • Role of Temperature and Humidity in Stability Testing (1)
    • Calibration and Validation of Stability Chambers (1)
    • Dealing with Temperature and Humidity Excursions in Stability Studies (1)
  • Biopharmaceutical Stability (6)
    • Challenges in Stability Testing for Biosimilars (1)
    • Stability Considerations for Gene and Cell Therapy Products (1)
    • Freeze-Drying and Lyophilization in Biologics Stability (1)
    • Packaging and Storage of Biopharmaceuticals (1)
    • Real-Time and Accelerated Stability Studies for Biologics (1)
  • Case Studies in Stability Testing (6)
    • Stability Testing Failures and Their Impact on Drug Safety (1)
    • Successful Stability Study Strategies in Drug Development (1)
    • Comparing Stability Data Across Different Climatic Zones (1)
    • How Stability Testing Influenced Global Drug Recalls (1)
    • Lessons from Regulatory Inspections on Stability Studies (1)
  • Pharmaceutical Packaging Stability (6)
    • Stability Studies for Primary vs. Secondary Packaging (1)
    • Role of Packaging in Protecting Against Drug Degradation (1)
    • Sustainable and Biodegradable Packaging for Pharmaceuticals (1)
    • Impact of Packaging Materials on Photostability and Humidity Control (1)
    • Container Closure Integrity Testing in Stability Studies (1)
  • Stability Studies in Emerging Markets (6)
    • Regulatory Challenges in Stability Testing for Emerging Markets (1)
    • Cost-Effective Stability Testing Solutions for Developing Countries (1)
    • Stability Testing for Tropical and High-Humidity Regions (1)
    • Stability Testing for Humanitarian and Emergency Drug Supplies (1)
    • Outsourcing Stability Testing to Emerging Markets (1)
  • Stability Data and Report Management (6)
    • Data Integrity in Stability Testing and Regulatory Compliance (1)
    • Data Integrity in Stability Testing and Regulatory Compliance (1)
    • Handling and Storing Stability Data for Regulatory Submissions (1)
    • Excursion Management in Stability Study Reports (1)
    • Advanced Data Analytics for Stability Study Evaluation (1)
    • Regulatory Audit Readiness for Stability Data Management (1)
  • Stability Studies for Specific Dosage Forms (6)
    • Stability Testing for Solid Dosage Forms (Tablets, Capsules) (1)
    • Stability Considerations for Liquid and Injectable Drugs (1)
    • Photostability and Humidity Impact on Semi-Solid Dosage Forms (2)
    • Ophthalmic and Inhalation Product Stability Studies (1)
    • Challenges in Stability Testing for Liposomal and Nanoparticle Formulations (1)
  • Regional Stability Guidelines (6)
    • FDA Stability Testing Requirements for US Market (1)
    • EMA Stability Guidelines for European Union (1)
    • TGA Stability Requirements for Australia (1)
    • ASEAN Stability Guidelines and Their Implementation (1)
    • Harmonizing Stability Protocols for Global Markets (1)
  • Educational Resources (6)
    • Step-by-Step Guide to Stability Studies for Beginners (1)
    • Understanding ICH Stability Guidelines and Their Impact (1)
    • How to Perform an Effective Stability Study (1)
    • Case Studies: Stability Testing Challenges and Solutions (1)
    • Stability Tutorials (61)
    • ‘How to’ – Stability Studies (200)
    • Free eBooks and PDFs on Stability Studies (1)
  • Packaging and Containers (28)
    • Packaging – Containers – Closers (99)
    • Pharmaceutical Containers and Closures for Stability (21)
    • Packaging Materials Impact on Stability Testing (3)
    • Container Closure Integrity Testing (1)
    • Compatibility of Drug Formulation with Packaging (1)
    • Sustainable Packaging for Drug Stability (1)
  • Biologics and Specialized Stability Testing (6)
    • Stability Testing for Peptide and Protein-Based Drugs (1)
    • Challenges in Stability Studies for Vaccines and Biologics (1)
    • Biopharmaceutical Storage and Stability Testing (1)
    • Stability Considerations for Personalized Medicine (1)
    • Advanced Analytical Techniques for Biologic Stability (1)
  • Insights and Innovations (7)
    • AI and Machine Learning in Stability Testing (1)
    • Digital Twins for Predictive Stability Study Simulations (1)
    • Blockchain in Stability Data Integrity (1)
    • Automation in Stability Chambers and Environmental Monitoring (1)
    • Future Trends in Stability Studies for Pharmaceuticals (1)
  • Trends in Stability Studies (6)
    • Sustainability in Stability Chambers and Testing Facilities (1)
    • Energy-Efficient and Green Chemistry Approaches in Stability Testing (1)
    • AI and Predictive Models for Shelf Life Determination (1)
    • Big Data and Cloud-Based Solutions in Stability Studies (1)
    • Innovative Packaging for Enhanced Drug Stability (1)
  • Nutraceutical and Herbal Product Stability (6)
    • Stability Testing Guidelines for Herbal Medicines (1)
    • Challenges in Stability Testing for Nutraceuticals and Dietary Supplements (1)
    • Regulatory Considerations for Herbal Product Stability Testing (1)
    • Role of Natural Preservatives in Enhancing Herbal Stability (1)
    • Shelf Life Testing for Botanical Drug Products (1)
  • Stability Testing Regulations Across Industries (6)
    • Stability Testing for Cosmetics and Personal Care Products (1)
    • Stability Testing for Veterinary Pharmaceuticals (1)
    • Regulatory Stability Requirements for Food and Beverage Industry (1)
    • ICH vs. ISO Standards for Stability Testing in Non-Pharma Sectors (1)
    • Global Compliance Strategies for Stability Testing in Various Industries (2)
  • Stability Studies for APIs (7)
    • Accelerated Stability Testing of APIs (3)
    • ICH Guidelines for API Stability (Q1A–Q1E, Q3C) (1)
    • Drug Degradation Pathways in API Stability (1)
    • Bracketing and Matrixing Designs for API Stability Studies (1)
    • Impact of Impurities on API Stability Data (1)
    • Stability Studies – API (51)
Widget Image
  • Use Distinctive Sample Containers for Investigation Lots

    Understanding the Tip: The role of container differentiation in deviation management: Investigation lots are often generated in response to OOS, OOT, or atypical stability trends.
    … Read more

Copyright © 2025 StabilityStudies.in.

Powered by PressBook WordPress theme